Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basementmembrane disease

Nephrology

Volumn 18, Issue 3, 2013, Pages 209-214

  Xin, Gang ^a   Cui, Zhao ^b   Su, Yun ^a   Xu, Li Xia ^c   Zhao, Ming Hui ^b   Li, Kang Sheng ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

a proliferation inducing ligand; anti glomerular basement membrane disease; B cell activating factor belonging to the tumour necrosis factor family

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; GLOMERULUS BASEMENT MEMBRANE ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; KIDNEY INJURY; MALE; PRIORITY JOURNAL;

ADULT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; B-CELL ACTIVATING FACTOR; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; UP-REGULATION; YOUNG ADULT;

EID: 84874475462     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12032     Document Type: Article

References (20)

1. Cui Z, Zhao MH,. Advances in human antiglomerular basement membrane disease. Nat. Rev. Nephrol. 2011; 7: 697-705.
2. Cui Z, Zhao J, Jia XY, et al. Anti-glomerular basement membrane disease: Outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine (Baltimore) 2011; 90: 303-311.
3. Mecklenbrauker I, Kalled SL, Leitges M, Mackay F, Tarakhovsky A,. Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling. Nature 2004; 431: 456-461.
4. Sun J, Lin Z, Feng J, Li Y, Shen B,. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases. Eur. J. Pharmacol. 2008; 597: 1-5.
5. Zhao LD, Li Y, Smith MF, Jr,. et al. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients. Lupus 2011; 19: 1534-1549.
6. Bosello S, Youinou P, Daridon C, et al. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J. Rheumatol. 2008; 35: 1256-1264.
7. Mariette X, Roux S, Zhang J, et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann. Rheum. Dis. 2003; 62: 168-171.
8. Groom J, Kalled SL, Cutler AH, et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 2002; 109: 59-68.
9. Pers JO, Daridon C, Devauchelle V, et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann. N. Y. Acad. Sci. 2005; 1050: 34-39.
10. Cui Z, Zhao MH,. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity. Clin. Immunol. 2005; 116: 77-82.
11. Chen M, Yu F, Zhang Y, Zhao MH,. Antineutrophil cytoplasmic autoantibody-Associated vasculitis in older patients. Medicine (Baltimore) 2008; 87: 203-209.
12. Do RK, Chen-Kiang S,. Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev. 2002; 13: 19-25.
13. Tangye SG, Bryant VL, Cuss AK, Good KL,. BAFF, APRIL and human B cell disorders. Semin. Immunol. 2006; 18: 305-317.
14. Schiemann B, Gommerman JL, Vora K, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001; 293: 2111-2114.
15. Liu Z, Davidson A,. BAFF inhibition: A new class of drugs for the treatment of autoimmunity. Exp. Cell Res. 2011; 317: 1270-1277.
16. Gross JA, Johnston J, Mudri S, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000; 404: 995-999.
17. Toubi E, Gordon S, Kessel A, et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity. J. Autoimmun. 2006; 27: 134-139.
18. Chen M, Cui Z, Zhao MH,. ANCA-Associated vasculitis and anti-GBM disease: The experience in China. Nephrol. Dial. Transplant. 2010; 25: 2062-2065.
19. Kambham N,. Crescentic Glomerulonephritis: An update on Pauci-immune and Anti-GBM diseases. Adv. Anat. Pathol. 2012; 19: 111-124.
20. Rutgers A, Slot M, van, Paassen P, van, Breda Vriesman P, Heeringa P, Tervaert JW,. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am. J. Kidney Dis. 2005; 46: 253-262.